N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.

[1]  V. Go,et al.  Epigenetic Regulation Affects N-myc Downstream-Regulated Gene 1 Expression Indirectly in Pancreatic Cancer Cells , 2010, Pancreas.

[2]  Monica C. Chen,et al.  Bioluminescence Imaging of Angiogenesis in a Murine Orthotopic Pancreatic Cancer Model , 2010, Molecular Imaging and Biology.

[3]  Guoqiang Chen,et al.  NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells. , 2009, Leukemia research.

[4]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[5]  H. Izumi,et al.  N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression. , 2009, Cancer research.

[6]  H. Reber,et al.  Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss. , 2008, Archives of surgery.

[7]  Paola Chiarugi,et al.  Anoikis: a necessary death program for anchorage-dependent cells. , 2008, Biochemical pharmacology.

[8]  T. Thompson,et al.  Antiproliferative effects of AVN944, a novel inosine 5‐monophosphate dehydrogenase inhibitor, in prostate cancer cells , 2008, International journal of cancer.

[9]  Junying Yuan,et al.  Caspases in apoptosis and beyond , 2008, Oncogene.

[10]  Mark J. Smyth,et al.  The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.

[11]  D. Saur,et al.  Apoptotic pathways in pancreatic ductal adenocarcinoma , 2008, Molecular Cancer.

[12]  H. Reber,et al.  Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. , 2008, Surgery.

[13]  S. So,et al.  N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. , 2008, Cancer letters.

[14]  K. Tchou-Wong,et al.  Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. , 2007, Cancer research.

[15]  C. Ko,et al.  National Failure to Operate on Early Stage Pancreatic Cancer , 2007, Annals of surgery.

[16]  Lan Liu,et al.  p53-dependent NDRG1 expression induces inhibition of intestinal epithelial cell proliferation but not apoptosis after polyamine depletion. , 2007, American journal of physiology. Cell physiology.

[17]  D. V. Von Hoff,et al.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma , 2007, Molecular Cancer Therapeutics.

[18]  L. Akslen,et al.  Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch , 2006, Cell cycle.

[19]  R. Weimann,et al.  Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer , 2006, British Journal of Cancer.

[20]  M. Kuwano,et al.  Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. , 2006, Cancer research.

[21]  H. Reber,et al.  The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling. , 2005, Cancer research.

[22]  Mina J Bissell,et al.  Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. , 2005, Seminars in cancer biology.

[23]  B. Sipos,et al.  Pancreatic fibrosis associated with age and ductal papillary hyperplasia , 2005, Virchows Archiv.

[24]  M. Westfall,et al.  NDRG1 Is Necessary for p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.

[25]  Ying Wang,et al.  PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer , 2004, Cancer Research.

[26]  Robin L. Anderson,et al.  Caveolin-1 inhibits breast cancer growth and metastasis , 2004, Oncogene.

[27]  I. Ninomiya,et al.  Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. , 2004, International journal of oncology.

[28]  J. Veltman,et al.  Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines. , 2004, Cancer research.

[29]  L. Kretzner,et al.  The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc , 2003, Molecular and Cellular Biochemistry.

[30]  S. Pandol,et al.  Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways. , 2003, Gastroenterology.

[31]  H. Buhr,et al.  An Orthotopic Nude Mouse Model for Evaluating Pathophysiology and Therapy of Pancreatic Cancer , 2003, Pancreas.

[32]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[33]  F. Bosman,et al.  Expression of NDRG1, a differentiation-related gene, in human tissues , 2002, Histochemistry and Cell Biology.

[34]  B. Wiedenmann,et al.  Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis , 2001, Gut.

[35]  S. Erdmann,et al.  Seven genes that are differentially transcribed in colorectal tumor cell lines. , 2000, Cancer letters.

[36]  H. Ford,et al.  Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.

[37]  L. Lin,et al.  Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis. , 1999, Biology of reproduction.

[38]  J. Swinnen,et al.  The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.

[39]  T. Commes,et al.  Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. , 1999, Biochimica et biophysica acta.

[40]  R. Schilsky,et al.  An investigational new drug treatment program for patients with gemcitabine , 1999, Cancer.

[41]  G. Giaccone,et al.  Current chemotherapeutic possibilities in pancreaticobiliary cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[42]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[43]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[44]  S. Basu,et al.  Current trends in the diagnosis and treatment of carcinoma of the pancreas. , 1983, American journal of surgery.